A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Biostatistics Core Facility Bookmark and Share

Biostatistics Core Facility

Director: Jeffrey Longmate, Ph.D.
Co-Director: David Smith, Ph.D.

The Biostatistics Core facility is a group of statisticians who collaborate in basic, translational, and clinical research in the Cancer Center. The Core is supported by City of Hope’s NCI-funded Cancer Center Support Grant (CCSG), and its services are available to City of Hope researchers.

”The central requirement for successful collaboration is clear, broad, specific, two-way communication on both scientific issues and research roles.”

-- Moses and Thomas, Chapter 18 in Medical Uses of Statistics, 2nd ed., NEJM Books, 1992

Scientific Issues: Areas of statistical expertise include: clinical trials; clinical epidemiology; genetic epidemiology; gene expression and functional genomics; pharmacokinetic modeling; assays, bioassays, and diagnostics; toxicology; and general statistical methods for data summary, inference and prediction;

Research Roles: Core members can help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.
 
Services
Collaboration is our main activity. The core statisticians generally contribute to the design and analysis of research projects as co-investigators and co-authors. We collaborate in basic, translational, clinical and population-based research.

Consulting is available to advise investigators on statistical issues in research. Consulting generally consists of one or two meetings, and it’s free. This is a good way to explore possible collaboration, or just get statistical questions answered.

Case finding: The core can provide HIPAA-compliant identification of patients with stored tissue samples or other characteristics.

Statistical Computing is provided in conjunction with collaboration.

To access services or to use the facility, please contact usat 626-256-HOPE (4673), ext. 61444 or viaemailto schedule an appointment.
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 

Abstract for Grants

The Biostatistics Core is directed by Dr. Jeffrey Longmate, Director of the Division of Biostatistics, with Dr. David D. Smith serving as Co-Director. The Biostatistics Core draws effort from a large part of the Division of Biostatistics, with the Biostatistics Core enabling their participation in Cancer Center-related pilot projects and proposals, which may later develop into externally funded projects.  The Biostatistics Core is directly involved in Cancer Center research from the inception of a research idea to the publication of results.

Clinical research projects account for the largest portion of core use, but the Biostatistics Core also supports basic and translational research, as well as assisting several other cores.  The Biostatistics Core staff collaborate closely with the Biomedical Informatics core to support data processing and analysis of gene expression microarrays, and the Biostatistics Core works closely with both the Clinical Research Informatics Core and the Clinical Trials Management Core to implement City of Hope-conducted or coordinated clinical protocols.  In addition to these ongoing collaborative efforts, there have been more technically-focused projects in which the Biostatistics Core has supported the other cores in the implementation of technologies that involve statistical measurement issues.  This has recently included the Affymetrix Core, the Clinical Immunobiology Correlative Studies Lab, and the Genotyping Core.
 
Services include:
Collaboration is our main activity.  The core statisticians generally contribute to the design and analysis of research projects as co-investigators and co-authors.   We collaborate in basic, translational, clinical and population-based research.
 
Consulting is available to advise investigators on statistical issues in research.  Consulting generally consists of one or two meetings, and it’s free.  This is a good way to explore possible collaboration, or just get statistical questions answered.
 
Case finding:  The core can provide HIPAA-compliant identification of patients with stored tissue samples or other characteristics.
 
Statistical Computing is provided in conjunction with collaboration.
 
The Division of Biostatistics is located in the Information Sciences Bldg. (Bldg. #171).
 

Using the Facility

The core encourages collaboration, so investigators are free to contact faculty statisticians directly. Investigators can request an introduction or consulting appointment by phone or email:
 
Phone: 626-256-HOPE (4673) Ext. 61444
Email: BiostatisticsCore
 
Investigators are encouraged to consult with a statistician early in their planning.
Any core-clearance forms required by administration should reflect collaborations already in place.

Pricing

An initial consulting appointment is available without charge.
 
Grant proposals should cover the effort of participating core staff.  The minimum effort for salary support on proposals is 5%.  Any smaller effort should be requested as an expense rather than personnel.
 
Clinical research projects without grants (e.g. internal or industry funding) should budget an estimated cost for core staff time.
 
In some circumstances (e.g. preliminary work for a grant proposal, a basic science project with an unanticipated need for statistical data analysis, or a small grant program that explicitly limits the use of funds) the investigator may request effort that is supported by core funds.  Not all requests can be accommodated.   Priority is given to Cancer Center members and grant proposals, with the expectation that future effort will be funded.
 

Biostatistics Core Directors

Jeffrey Longmate, Ph.D.
Director
626-256-HOPE (4673), 62478
jlongmate@coh.org

David Smith, Ph.D.
Co-Director
626-256-HOPE (4673)
dsmith02@coh.org
 
Location
City of Hope and Beckman Research Institute
1500 East Duarte Road
Duarte, CA  91010-3000
 
Information Sciences Building (#171)
Phone:  626-256-HOPE (4673), Ext. 61444
Fax:  626-471-7106 or 626-301-8802
 

Biostatistics Core Directors

Biostatistics Core Facility

Biostatistics Core Facility

Director: Jeffrey Longmate, Ph.D.
Co-Director: David Smith, Ph.D.

The Biostatistics Core facility is a group of statisticians who collaborate in basic, translational, and clinical research in the Cancer Center. The Core is supported by City of Hope’s NCI-funded Cancer Center Support Grant (CCSG), and its services are available to City of Hope researchers.

”The central requirement for successful collaboration is clear, broad, specific, two-way communication on both scientific issues and research roles.”

-- Moses and Thomas, Chapter 18 in Medical Uses of Statistics, 2nd ed., NEJM Books, 1992

Scientific Issues: Areas of statistical expertise include: clinical trials; clinical epidemiology; genetic epidemiology; gene expression and functional genomics; pharmacokinetic modeling; assays, bioassays, and diagnostics; toxicology; and general statistical methods for data summary, inference and prediction;

Research Roles: Core members can help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.
 
Services
Collaboration is our main activity. The core statisticians generally contribute to the design and analysis of research projects as co-investigators and co-authors. We collaborate in basic, translational, clinical and population-based research.

Consulting is available to advise investigators on statistical issues in research. Consulting generally consists of one or two meetings, and it’s free. This is a good way to explore possible collaboration, or just get statistical questions answered.

Case finding: The core can provide HIPAA-compliant identification of patients with stored tissue samples or other characteristics.

Statistical Computing is provided in conjunction with collaboration.

To access services or to use the facility, please contact usat 626-256-HOPE (4673), ext. 61444 or viaemailto schedule an appointment.
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 

Abstract for Grants

Abstract for Grants

The Biostatistics Core is directed by Dr. Jeffrey Longmate, Director of the Division of Biostatistics, with Dr. David D. Smith serving as Co-Director. The Biostatistics Core draws effort from a large part of the Division of Biostatistics, with the Biostatistics Core enabling their participation in Cancer Center-related pilot projects and proposals, which may later develop into externally funded projects.  The Biostatistics Core is directly involved in Cancer Center research from the inception of a research idea to the publication of results.

Clinical research projects account for the largest portion of core use, but the Biostatistics Core also supports basic and translational research, as well as assisting several other cores.  The Biostatistics Core staff collaborate closely with the Biomedical Informatics core to support data processing and analysis of gene expression microarrays, and the Biostatistics Core works closely with both the Clinical Research Informatics Core and the Clinical Trials Management Core to implement City of Hope-conducted or coordinated clinical protocols.  In addition to these ongoing collaborative efforts, there have been more technically-focused projects in which the Biostatistics Core has supported the other cores in the implementation of technologies that involve statistical measurement issues.  This has recently included the Affymetrix Core, the Clinical Immunobiology Correlative Studies Lab, and the Genotyping Core.
 
Services include:
Collaboration is our main activity.  The core statisticians generally contribute to the design and analysis of research projects as co-investigators and co-authors.   We collaborate in basic, translational, clinical and population-based research.
 
Consulting is available to advise investigators on statistical issues in research.  Consulting generally consists of one or two meetings, and it’s free.  This is a good way to explore possible collaboration, or just get statistical questions answered.
 
Case finding:  The core can provide HIPAA-compliant identification of patients with stored tissue samples or other characteristics.
 
Statistical Computing is provided in conjunction with collaboration.
 
The Division of Biostatistics is located in the Information Sciences Bldg. (Bldg. #171).
 

Using the Facility

Using the Facility

The core encourages collaboration, so investigators are free to contact faculty statisticians directly. Investigators can request an introduction or consulting appointment by phone or email:
 
Phone: 626-256-HOPE (4673) Ext. 61444
Email: BiostatisticsCore
 
Investigators are encouraged to consult with a statistician early in their planning.
Any core-clearance forms required by administration should reflect collaborations already in place.

Pricing

Pricing

An initial consulting appointment is available without charge.
 
Grant proposals should cover the effort of participating core staff.  The minimum effort for salary support on proposals is 5%.  Any smaller effort should be requested as an expense rather than personnel.
 
Clinical research projects without grants (e.g. internal or industry funding) should budget an estimated cost for core staff time.
 
In some circumstances (e.g. preliminary work for a grant proposal, a basic science project with an unanticipated need for statistical data analysis, or a small grant program that explicitly limits the use of funds) the investigator may request effort that is supported by core funds.  Not all requests can be accommodated.   Priority is given to Cancer Center members and grant proposals, with the expectation that future effort will be funded.
 

Contact Us

Biostatistics Core Directors

Jeffrey Longmate, Ph.D.
Director
626-256-HOPE (4673), 62478
jlongmate@coh.org

David Smith, Ph.D.
Co-Director
626-256-HOPE (4673)
dsmith02@coh.org
 
Location
City of Hope and Beckman Research Institute
1500 East Duarte Road
Duarte, CA  91010-3000
 
Information Sciences Building (#171)
Phone:  626-256-HOPE (4673), Ext. 61444
Fax:  626-471-7106 or 626-301-8802
 

Biostatistics Core Facility Directors

Biostatistics Core Directors

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...